Communicable Disease Reporting
Announcements:
COVID-19 Lab Reporting Guidance Update: COVID-19 lab results that are not sent electronically, including point-of-care test (POC) results, are no longer required to be reported to the Indiana Department of Health (IDOH), effective immediately. Laboratories and testing sites that submit results via electronic lab reporting (ELR) are still required to report SARS-CoV-2 results to IDOH (HL7 or CSV files), per the Indiana Communicable Disease (CD) Rule (410 IAC). The POC REDCap platform used for submitting COVID-19 test results will be closed.
The following document covers the change in greater detail:
Requirements for Laboratory Reporting of COVID-19 Test Results
Communicable disease reporting changes went into effect April 1.
In March 2023, the Indiana Department of Health (IDOH) announced changes to Indiana’s Communicable Disease (CD) Rule (410 IAC), including streamlined timeframes for reporting and updates to reportable diseases. Indiana Code Title 16 (Health 16-41-2-1) was amended in 2019. This amendment allows the IDOH to publish and update the list of reportable communicable diseases and control measures on the IDOH website. External documents have been created to house this information, which will allow for updates and changes to be made more easily in the future.
The following documents cover the changes in greater detail:
Indiana Reportable Disease List for Healthcare Providers and Hospitals
- Report Immediately on Suspicion
How to Report
Step 1:
Call (317) 233-7125 (weekdays 8:15 a.m. to 4:45 p.m. EST) or (317) 233-1325 (after hours)Step 2:
NBS Users: Report conditions via Morbidity Report in NBS
Non-NBS Users: Report via the following reporting form: Confidential Report of Communicable Diseases- Anthrax
- Botulism
- Cholera (Vibrio cholerae O1, O139, or toxigenic)
- Diphtheria
- Eastern equine encephalitis virus (EEEV) disease
- Hemolytic uremic syndrome (HUS), post-diarrheal
- Hepatitis, viral, Type B, pregnant woman (acute and chronic) or perinatally exposed infant
- Influenza A, Novel
- Measles (Rubeola)
- Melioidosis (Burkholderia pseudomallei)
- Meningococcal disease, invasive
- Middle East Respiratory Syndrome (MERS)
- Plague
- Poliomyelitis
- Rabies, human
- Rubella (German Measles)
- Rubella congenital syndrome
- Severe Acute Respiratory Syndrome (SARS)
- Smallpox (Variola infection)
- Tularemia
- Viral hemorrhagic fever, filoviruses
- Ebola virus
- Marburg virus
- Viral hemorrhagic fever, other
- Crimean-Congohemorrhagic fever virus
- Guanarito virus
- Junin virus
- Lassa virus
- Lujo virus
- Machupo virus
- Sabia virus
- Report Within One Working Day
How to Report
NBS Users: Report conditions via Morbidity Report in NBS
Note: LTBI should be reported as an Investigation in NBS instead of via a Morbidity ReportNon-NBS Users: Report via the specific reporting form below:
- STIs and HIV/AIDS
- Tuberculosis (cases & suspects)
- Latent TB infection
- Animal bites
- All other reportable conditions
- Acquired Immunodeficiency Syndrome (AIDS)
- Acute Flaccid Myelitis (AFM)
- Anaplasmosis
- Animal bite or exposure
- Arboviral disease or infection, domestic
- West Nile virus (WNV)
- St. Louis encephalitis virus (SLEV)
- Western equine encephalitis virus (WEEV)
- California serogroup viruses
- (La Crosse virus (LACV)
- Jamestown Canyon virus (JCV))
- Powassan virus (POWV)
- Arboviral disease or infection, imported
- Chikungunya virus (CHIKV)
- Dengue virus (DENV)
- Zika virus (ZIKV)
- Babesiosis
- Brucellosis
- Campylobacteriosis
- Candida auris and unusual Candida spp. (species other than C. albicans, C. parapsilosis, C. dubliniensis, C. lusitaniae, C. tropicalis or C. krusei)
- Carbapenemase-Producing Organisms (CPO)
- Chancroid
- Chlamydia trachomatis, genital infection
- Lymphogranuloma venereum
- Coccidioidomycosis
- COVID-19, cases and deaths
- Cryptosporidiosis
- Cyclosporiasis
- Ehrlichiosis
- Escherichia coli (E. coli) infection (Shiga toxin-producing E. coli (STEC)) including, but not limited to, E. coli O157 and other serogroups)
- Giardiasis
- Gonorrhea Disseminated gonococcal infection
- Granuloma inguinale
- Haemophilus influenzae, invasive disease, (including antimicrobial susceptibility testing)
- Hansen’s disease (leprosy)
- Hantavirus infection (pulmonary and non-pulmonary), including, but not limited to: Sin Nombre virus Seoul virus
- Hepatitis, viral, Type A
- Hepatitis, viral, Type B (acute and chronic)
- Hepatitis, viral, Type C (acute and chronic)
- Hepatitis, viral, Type C, pregnant woman (acute or chronic) or perinatally exposed infant
- Hepatitis, viral, Type Delta
- Hepatitis, viral, Type E
- Hepatitis, viral, unspecified
- Histoplasmosis
- HIV infection/disease
- HIV infection/disease, pregnant woman or perinatally exposed infant
- Influenza-associated death (all ages)
- Japanese encephalitis
- Latent tuberculosis infection (LTBI)
- Legionellosis
- Leptospirosis
- Listeriosis
- Lyme disease
- Lymphocytic choriomeningitis virus
- Malaria
- Mpox (formerly known as Monkeypox)
- Multisystem Inflammatory Syndrome in adults (MIS-A)
- Multisystem Inflammatory Syndrome in children (MIS-C)
- Mumps
- Pandrug-resistant Organisms
- Pertussis
- Psittacosis
- Q Fever
- Rabies, postexposure prophylaxis administration
- Salmonellosis, nontyphoidal
- Shigellosis
- Spotted fever rickettsiosis, including Rocky Mountain Spotted fever
- Streptococcus pneumoniae, invasive disease (including antimicrobial susceptibility testing)
- Streptococcus, Group A, invasive disease
- Syphilis
- Tetanus
- Toxic shock syndrome (streptococcal or staphylococcal)
- Trichinellosis
- Tuberculosis disease, cases and suspects
- Typhoid and paratyphoid fever, cases and carriers
- Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin intermediate Staphylococcus aureus (VISA)
- Varicella (chicken pox)
- Vibriosis (non-cholera Vibrio infection)
- Yellow fever
- Yersiniosis, Non-pestis
Indiana Reportable Result/Pathogen List for Laboratories
- Report Immediately on Suspicion
How to Report
For immediate reporting call: (317) 233-7125 (weekdays 8:15 a.m. to 4:45 p.m. EST) or (317) 233-1325 (after hours)Please also report via electronic laboratory reporting.
For facilities unable to submit via ELR, please fax reports to 317-234-2812.
- Bacillus anthracis
- Burkholderia mallei
- Burkholderia pseudomallei
- Clostridium botulinum
- Corynebacterium diphtheriae
- Eastern equine encephalitis virus
- Francisella tularensis
- Hepatitis, viral, type B, pregnant woman (acute and chronic) or perinatally exposed infant†
- Measles virus
- Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
- Neisseria meningitidis, invasive disease
- Novel influenza A
- Poliovirus
- Rabies virus
- Rubella virus
- SARS-associated coronavirus (SARS-CoV)
- Smallpox (variola) virus
- Viral hemorrhagic fever, filoviruses
- Ebola virus
- Marburg virus
- Vibrio cholerae O1, O139, or toxigenic
- Viral hemorrhagic fever, other
- Crimean-Congo hemorrhagic fever virus
- Guanarito virus
- Junin virus
- Lassa virus
- Lujo virus
- Machupo virus
- Sabia virus
- Yersinia pestis
† Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories
- Report Within One Working Day
How to Report
Report via electronic laboratory reporting.
For facilities unable to submit via ELR, please fax reports to 317-234-2812.
- Anaplasma spp.
- Arboviruses including, but not limited to:
- Chikungunya virus
- Dengue virus
- Jamestown Canyon virus
- Japanese encephalitis virus
- La Crosse (California serogroup) viruses
- Powassan virus
- St. Louis encephalitis virus
- Western equine encephalitis virus
- West Nile virus
- Zika virus
- Babesia spp.
- Bordetella pertussis
- Borrelia burgdorferi
- Brucella spp.
- Campylobacter spp.
- Candida auris and unusual Candida spp. (Species
other than C. albicans, C. parapsilosis, C. dubliniensis, C. lusitaniae, C. tropicalis, or C. krusei) - Carbapenemase-producing Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii*
- Chlamydia psittaci
- Chlamydia trachomatis Lymphogranuloma venereum (LGV) (C. trachomatis serotypes L1, L2, or L3)
- Clostridium tetani
- Coccidioides spp.
- Coxiella burnetii
- Cryptosporidium spp.
- Cyclospora cayetanensis
- Ehrlichia spp.
- Escherichia coli (E. coli) infection (Shiga toxin-producing (STEC), including but not limited to, E. coli O157, E. coli O157:H7,non-O157 E. coli, and Shiga toxin detected*
- Giardia spp.
- Grimontia hollisae (Vibrio hollisae)
- Haemophilus ducreyi
- Haemophilus influenzae, invasive disease*
- Hantavirus
- Hepatitis, viral, Type A, Anti-HAV IgM or RNA detected
- Hepatitis, viral, Type B†
- Hepatitis, viral, Type C†
- Hepatitis, viral, Type Delta†
- Hepatitis, viral, Type E, Anti-HEV IgM and IgG
- Hepatitis, viral, unspecified
- Histoplasma capsulatum
- HIV and related retroviruses
- Influenza
- Interferon gamma release assay (IGRA) for tuberculosis (positive results only)
- Legionella spp.
- Leptospira spp.
- Listeria monocytogenes
- Lymphocytic choriomeningitis virus
- Mpox (Monkeypox) virus, including Non-variola Orthopox virus and Orthopox virus
- Mumps virus
- Mycobacterium leprae
- Mycobacterium tuberculosis
- Neisseria gonorrhoeae (list anatomic site to determine if disseminated infection)*
- Pandrug-resistant Organisms*
- Photobacterium damselae (Vibrio damsela)
- Plasmodium spp.
- Pneumocystis carinii (Pneumocystis pneumonia)
- Rickettsia (non-rickettsii spp.)
- Rickettsia rickettsii
- Salmonella spp. (non-typhoidal)*
- Salmonella serotype Paratyphi (Paratyphoid fever)*
- Salmonella serotype Typhi (Typhoid fever)*
- SARS-CoV-2
- Shigella spp.*
- Streptococcus, group A (Streptococcus pyogenes), invasive disease*
- Streptococcus pneumoniae, invasive disease*
- Treponema pallidum
- Trichinella spiralis
- Vancomycin-resistant Staphylococcus aureus (VRSA) and Vancomycin intermediate Staphylococcus aureus (VISA)*
- Varicella-zoster virus
- Vibrio spp.
- West African monkeypox virus
- Yellow fever virus
- Yersinia spp., Enterocolitica, Pseudotuberculosis
* Include antimicrobial susceptibility testing
† Further guidance on the second page of the Indiana Reportable Result/Pathogen List for Laboratories
Additional Resources
- 2015 Communicable Disease Reporting Rule
- The Indiana Reportable Disease List for Healthcare Providers and Hospitals & the Indiana Reportable Result_Pathogen List for Laboratories have been removed from the CD Rule, revised, and are now housed in separate documents. Please see current versions above.
- COVID-19 Control Measures (updated Feb. 23, 2022)
- Local Health Department Guidance on Communicable Disease Laws (updated July 26, 2021)
- HIPAA and Public Health Letter
- HIPAA Exemption
